世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anti–Oral Mucositis Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0406
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、抗口腔粘膜炎薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（うがい薬、鎮痛薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・抗口腔粘膜炎薬の市場動向
・企業の競争状況、市場シェア
・抗口腔粘膜炎薬の種類別市場規模（うがい薬、鎮痛薬、その他）
・抗口腔粘膜炎薬の用途別市場規模（病院、クリニック、その他）
・抗口腔粘膜炎薬の北米市場規模2016-2027（アメリカ、カナダ）
・抗口腔粘膜炎薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗口腔粘膜炎薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗口腔粘膜炎薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗口腔粘膜炎薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（3M Healthcare、GSK、Pfizer、Colgate-Palmolive、Norgine、Biovitrum、Bausch Health、EUSA Pharma、Camurus、Mission Pharmacal、Clinigen Group、Midatech Pharma、Alliance Pharma、AMAG Pharmaceuticals）
・結論

Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market
The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti–Oral Mucositis Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti–Oral Mucositis Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti–Oral Mucositis Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti–Oral Mucositis Drug market.

Global Anti–Oral Mucositis Drug Scope and Market Size
Anti–Oral Mucositis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti–Oral Mucositis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mouthwash
Pain Control Medication
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
3M Healthcare
GSK
Pfizer
Colgate-Palmolive
Norgine
Biovitrum
Bausch Health
EUSA Pharma
Camurus
Mission Pharmacal
Clinigen Group
Midatech Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti–Oral Mucositis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mouthwash
1.2.3 Pain Control Medication
1.2.4 Other
1.3 Market by Application
1.3.1 Global Anti–Oral Mucositis Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti–Oral Mucositis Drug Market Perspective (2016-2027)
2.2 Anti–Oral Mucositis Drug Growth Trends by Regions
2.2.1 Anti–Oral Mucositis Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti–Oral Mucositis Drug Historic Market Share by Regions (2016-2021)
2.2.3 Anti–Oral Mucositis Drug Forecasted Market Size by Regions (2022-2027)
2.3 Anti–Oral Mucositis Drug Industry Dynamic
2.3.1 Anti–Oral Mucositis Drug Market Trends
2.3.2 Anti–Oral Mucositis Drug Market Drivers
2.3.3 Anti–Oral Mucositis Drug Market Challenges
2.3.4 Anti–Oral Mucositis Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti–Oral Mucositis Drug Players by Revenue
3.1.1 Global Top Anti–Oral Mucositis Drug Players by Revenue (2016-2021)
3.1.2 Global Anti–Oral Mucositis Drug Revenue Market Share by Players (2016-2021)
3.2 Global Anti–Oral Mucositis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti–Oral Mucositis Drug Revenue
3.4 Global Anti–Oral Mucositis Drug Market Concentration Ratio
3.4.1 Global Anti–Oral Mucositis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti–Oral Mucositis Drug Revenue in 2020
3.5 Anti–Oral Mucositis Drug Key Players Head office and Area Served
3.6 Key Players Anti–Oral Mucositis Drug Product Solution and Service
3.7 Date of Enter into Anti–Oral Mucositis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti–Oral Mucositis Drug Breakdown Data by Type
4.1 Global Anti–Oral Mucositis Drug Historic Market Size by Type (2016-2021)
4.2 Global Anti–Oral Mucositis Drug Forecasted Market Size by Type (2022-2027)

5 Anti–Oral Mucositis Drug Breakdown Data by Application
5.1 Global Anti–Oral Mucositis Drug Historic Market Size by Application (2016-2021)
5.2 Global Anti–Oral Mucositis Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti–Oral Mucositis Drug Market Size (2016-2027)
6.2 North America Anti–Oral Mucositis Drug Market Size by Type
6.2.1 North America Anti–Oral Mucositis Drug Market Size by Type (2016-2021)
6.2.2 North America Anti–Oral Mucositis Drug Market Size by Type (2022-2027)
6.2.3 North America Anti–Oral Mucositis Drug Market Size by Type (2016-2027)
6.3 North America Anti–Oral Mucositis Drug Market Size by Application
6.3.1 North America Anti–Oral Mucositis Drug Market Size by Application (2016-2021)
6.3.2 North America Anti–Oral Mucositis Drug Market Size by Application (2022-2027)
6.3.3 North America Anti–Oral Mucositis Drug Market Size by Application (2016-2027)
6.4 North America Anti–Oral Mucositis Drug Market Size by Country
6.4.1 North America Anti–Oral Mucositis Drug Market Size by Country (2016-2021)
6.4.2 North America Anti–Oral Mucositis Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Anti–Oral Mucositis Drug Market Size (2016-2027)
7.2 Europe Anti–Oral Mucositis Drug Market Size by Type
7.2.1 Europe Anti–Oral Mucositis Drug Market Size by Type (2016-2021)
7.2.2 Europe Anti–Oral Mucositis Drug Market Size by Type (2022-2027)
7.2.3 Europe Anti–Oral Mucositis Drug Market Size by Type (2016-2027)
7.3 Europe Anti–Oral Mucositis Drug Market Size by Application
7.3.1 Europe Anti–Oral Mucositis Drug Market Size by Application (2016-2021)
7.3.2 Europe Anti–Oral Mucositis Drug Market Size by Application (2022-2027)
7.3.3 Europe Anti–Oral Mucositis Drug Market Size by Application (2016-2027)
7.4 Europe Anti–Oral Mucositis Drug Market Size by Country
7.4.1 Europe Anti–Oral Mucositis Drug Market Size by Country (2016-2021)
7.4.2 Europe Anti–Oral Mucositis Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti–Oral Mucositis Drug Market Size (2016-2027)
8.2 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Type
8.2.1 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Application
8.3.1 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Region
8.4.1 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti–Oral Mucositis Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti–Oral Mucositis Drug Market Size (2016-2027)
9.2 Latin America Anti–Oral Mucositis Drug Market Size by Type
9.2.1 Latin America Anti–Oral Mucositis Drug Market Size by Type (2016-2021)
9.2.2 Latin America Anti–Oral Mucositis Drug Market Size by Type (2022-2027)
9.2.3 Latin America Anti–Oral Mucositis Drug Market Size by Type (2016-2027)
9.3 Latin America Anti–Oral Mucositis Drug Market Size by Application
9.3.1 Latin America Anti–Oral Mucositis Drug Market Size by Application (2016-2021)
9.3.2 Latin America Anti–Oral Mucositis Drug Market Size by Application (2022-2027)
9.3.3 Latin America Anti–Oral Mucositis Drug Market Size by Application (2016-2027)
9.4 Latin America Anti–Oral Mucositis Drug Market Size by Country
9.4.1 Latin America Anti–Oral Mucositis Drug Market Size by Country (2016-2021)
9.4.2 Latin America Anti–Oral Mucositis Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti–Oral Mucositis Drug Market Size (2016-2027)
10.2 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Type
10.2.1 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Application
10.3.1 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Country
10.4.1 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti–Oral Mucositis Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 3M Healthcare
11.1.1 3M Healthcare Company Details
11.1.2 3M Healthcare Business Overview
11.1.3 3M Healthcare Anti–Oral Mucositis Drug Introduction
11.1.4 3M Healthcare Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.1.5 3M Healthcare Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Anti–Oral Mucositis Drug Introduction
11.2.4 GSK Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Anti–Oral Mucositis Drug Introduction
11.3.4 Pfizer Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Colgate-Palmolive
11.4.1 Colgate-Palmolive Company Details
11.4.2 Colgate-Palmolive Business Overview
11.4.3 Colgate-Palmolive Anti–Oral Mucositis Drug Introduction
11.4.4 Colgate-Palmolive Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.4.5 Colgate-Palmolive Recent Development
11.5 Norgine
11.5.1 Norgine Company Details
11.5.2 Norgine Business Overview
11.5.3 Norgine Anti–Oral Mucositis Drug Introduction
11.5.4 Norgine Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.5.5 Norgine Recent Development
11.6 Biovitrum
11.6.1 Biovitrum Company Details
11.6.2 Biovitrum Business Overview
11.6.3 Biovitrum Anti–Oral Mucositis Drug Introduction
11.6.4 Biovitrum Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.6.5 Biovitrum Recent Development
11.7 Bausch Health
11.7.1 Bausch Health Company Details
11.7.2 Bausch Health Business Overview
11.7.3 Bausch Health Anti–Oral Mucositis Drug Introduction
11.7.4 Bausch Health Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.7.5 Bausch Health Recent Development
11.8 EUSA Pharma
11.8.1 EUSA Pharma Company Details
11.8.2 EUSA Pharma Business Overview
11.8.3 EUSA Pharma Anti–Oral Mucositis Drug Introduction
11.8.4 EUSA Pharma Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.8.5 EUSA Pharma Recent Development
11.9 Camurus
11.9.1 Camurus Company Details
11.9.2 Camurus Business Overview
11.9.3 Camurus Anti–Oral Mucositis Drug Introduction
11.9.4 Camurus Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.9.5 Camurus Recent Development
11.10 Mission Pharmacal
11.10.1 Mission Pharmacal Company Details
11.10.2 Mission Pharmacal Business Overview
11.10.3 Mission Pharmacal Anti–Oral Mucositis Drug Introduction
11.10.4 Mission Pharmacal Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.10.5 Mission Pharmacal Recent Development
11.11 Clinigen Group
11.11.1 Clinigen Group Company Details
11.11.2 Clinigen Group Business Overview
11.11.3 Clinigen Group Anti–Oral Mucositis Drug Introduction
11.11.4 Clinigen Group Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.11.5 Clinigen Group Recent Development
11.12 Midatech Pharma
11.12.1 Midatech Pharma Company Details
11.12.2 Midatech Pharma Business Overview
11.12.3 Midatech Pharma Anti–Oral Mucositis Drug Introduction
11.12.4 Midatech Pharma Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.12.5 Midatech Pharma Recent Development
11.13 Alliance Pharma
11.13.1 Alliance Pharma Company Details
11.13.2 Alliance Pharma Business Overview
11.13.3 Alliance Pharma Anti–Oral Mucositis Drug Introduction
11.13.4 Alliance Pharma Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.13.5 Alliance Pharma Recent Development
11.14 AMAG Pharmaceuticals
11.14.1 AMAG Pharmaceuticals Company Details
11.14.2 AMAG Pharmaceuticals Business Overview
11.14.3 AMAG Pharmaceuticals Anti–Oral Mucositis Drug Introduction
11.14.4 AMAG Pharmaceuticals Revenue in Anti–Oral Mucositis Drug Business (2016-2021)
11.14.5 AMAG Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti–Oral Mucositis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mouthwash
Table 3. Key Players of Pain Control Medication
Table 4. Key Players of Other
Table 5. Global Anti–Oral Mucositis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti–Oral Mucositis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti–Oral Mucositis Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anti–Oral Mucositis Drug Market Share by Regions (2016-2021)
Table 9. Global Anti–Oral Mucositis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anti–Oral Mucositis Drug Market Share by Regions (2022-2027)
Table 11. Anti–Oral Mucositis Drug Market Trends
Table 12. Anti–Oral Mucositis Drug Market Drivers
Table 13. Anti–Oral Mucositis Drug Market Challenges
Table 14. Anti–Oral Mucositis Drug Market Restraints
Table 15. Global Anti–Oral Mucositis Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anti–Oral Mucositis Drug Market Share by Players (2016-2021)
Table 17. Global Top Anti–Oral Mucositis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti–Oral Mucositis Drug as of 2020)
Table 18. Ranking of Global Top Anti–Oral Mucositis Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anti–Oral Mucositis Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti–Oral Mucositis Drug Product Solution and Service
Table 22. Date of Enter into Anti–Oral Mucositis Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti–Oral Mucositis Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anti–Oral Mucositis Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Anti–Oral Mucositis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anti–Oral Mucositis Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anti–Oral Mucositis Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anti–Oral Mucositis Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Anti–Oral Mucositis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anti–Oral Mucositis Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anti–Oral Mucositis Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anti–Oral Mucositis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anti–Oral Mucositis Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anti–Oral Mucositis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anti–Oral Mucositis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anti–Oral Mucositis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anti–Oral Mucositis Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anti–Oral Mucositis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anti–Oral Mucositis Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anti–Oral Mucositis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anti–Oral Mucositis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anti–Oral Mucositis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anti–Oral Mucositis Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anti–Oral Mucositis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti–Oral Mucositis Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti–Oral Mucositis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti–Oral Mucositis Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anti–Oral Mucositis Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anti–Oral Mucositis Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anti–Oral Mucositis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anti–Oral Mucositis Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anti–Oral Mucositis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anti–Oral Mucositis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anti–Oral Mucositis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anti–Oral Mucositis Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anti–Oral Mucositis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti–Oral Mucositis Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti–Oral Mucositis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti–Oral Mucositis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anti–Oral Mucositis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. 3M Healthcare Company Details
Table 63. 3M Healthcare Business Overview
Table 64. 3M Healthcare Anti–Oral Mucositis Drug Product
Table 65. 3M Healthcare Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 66. 3M Healthcare Recent Development
Table 67. GSK Company Details
Table 68. GSK Business Overview
Table 69. GSK Anti–Oral Mucositis Drug Product
Table 70. GSK Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 71. GSK Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Anti–Oral Mucositis Drug Product
Table 75. Pfizer Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Colgate-Palmolive Company Details
Table 78. Colgate-Palmolive Business Overview
Table 79. Colgate-Palmolive Anti–Oral Mucositis Drug Product
Table 80. Colgate-Palmolive Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 81. Colgate-Palmolive Recent Development
Table 82. Norgine Company Details
Table 83. Norgine Business Overview
Table 84. Norgine Anti–Oral Mucositis Drug Product
Table 85. Norgine Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 86. Norgine Recent Development
Table 87. Biovitrum Company Details
Table 88. Biovitrum Business Overview
Table 89. Biovitrum Anti–Oral Mucositis Drug Product
Table 90. Biovitrum Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 91. Biovitrum Recent Development
Table 92. Bausch Health Company Details
Table 93. Bausch Health Business Overview
Table 94. Bausch Health Anti–Oral Mucositis Drug Product
Table 95. Bausch Health Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 96. Bausch Health Recent Development
Table 97. EUSA Pharma Company Details
Table 98. EUSA Pharma Business Overview
Table 99. EUSA Pharma Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 100. EUSA Pharma Recent Development
Table 101. Camurus Company Details
Table 102. Camurus Business Overview
Table 103. Camurus Anti–Oral Mucositis Drug Product
Table 104. Camurus Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 105. Camurus Recent Development
Table 106. Mission Pharmacal Company Details
Table 107. Mission Pharmacal Business Overview
Table 108. Mission Pharmacal Anti–Oral Mucositis Drug Product
Table 109. Mission Pharmacal Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 110. Mission Pharmacal Recent Development
Table 111. Clinigen Group Company Details
Table 112. Clinigen Group Business Overview
Table 113. Clinigen Group Anti–Oral Mucositis Drug Product
Table 114. Clinigen Group Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 115. Clinigen Group Recent Development
Table 116. Midatech Pharma Company Details
Table 117. Midatech Pharma Business Overview
Table 118. Midatech Pharma Anti–Oral Mucositis Drug Product
Table 119. Midatech Pharma Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 120. Midatech Pharma Recent Development
Table 121. Alliance Pharma Company Details
Table 122. Alliance Pharma Business Overview
Table 123. Alliance Pharma Anti–Oral Mucositis Drug Product
Table 124. Alliance Pharma Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 125. Alliance Pharma Recent Development
Table 126. AMAG Pharmaceuticals Company Details
Table 127. AMAG Pharmaceuticals Business Overview
Table 128. AMAG Pharmaceuticals Anti–Oral Mucositis Drug Product
Table 129. AMAG Pharmaceuticals Revenue in Anti–Oral Mucositis Drug Business (2016-2021) & (US$ Million)
Table 130. AMAG Pharmaceuticals Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti–Oral Mucositis Drug Market Share by Type: 2020 VS 2027
Figure 2. Mouthwash Features
Figure 3. Pain Control Medication Features
Figure 4. Other Features
Figure 5. Global Anti–Oral Mucositis Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Anti–Oral Mucositis Drug Report Years Considered
Figure 10. Global Anti–Oral Mucositis Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Anti–Oral Mucositis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anti–Oral Mucositis Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Anti–Oral Mucositis Drug Market Share by Regions (2022-2027)
Figure 14. Global Anti–Oral Mucositis Drug Market Share by Players in 2020
Figure 15. Global Top Anti–Oral Mucositis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti–Oral Mucositis Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Anti–Oral Mucositis Drug Revenue in 2020
Figure 17. Global Anti–Oral Mucositis Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Anti–Oral Mucositis Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Anti–Oral Mucositis Drug Market Share by Type (2016-2027)
Figure 21. North America Anti–Oral Mucositis Drug Market Share by Application (2016-2027)
Figure 22. North America Anti–Oral Mucositis Drug Market Share by Country (2016-2027)
Figure 23. United States Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anti–Oral Mucositis Drug Market Share by Type (2016-2027)
Figure 27. Europe Anti–Oral Mucositis Drug Market Share by Application (2016-2027)
Figure 28. Europe Anti–Oral Mucositis Drug Market Share by Country (2016-2027)
Figure 29. Germany Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anti–Oral Mucositis Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Anti–Oral Mucositis Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Anti–Oral Mucositis Drug Market Share by Region (2016-2027)
Figure 39. China Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anti–Oral Mucositis Drug Market Share by Type (2016-2027)
Figure 47. Latin America Anti–Oral Mucositis Drug Market Share by Application (2016-2027)
Figure 48. Latin America Anti–Oral Mucositis Drug Market Share by Country (2016-2027)
Figure 49. Mexico Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anti–Oral Mucositis Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Anti–Oral Mucositis Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Anti–Oral Mucositis Drug Market Share by Country (2016-2027)
Figure 55. Turkey Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Anti–Oral Mucositis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. 3M Healthcare Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 59. GSK Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 61. Colgate-Palmolive Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 62. Norgine Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 63. Biovitrum Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 64. Bausch Health Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 65. EUSA Pharma Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 66. Camurus Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 67. Mission Pharmacal Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 68. Clinigen Group Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 69. Midatech Pharma Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 70. Alliance Pharma Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 71. AMAG Pharmaceuticals Revenue Growth Rate in Anti–Oral Mucositis Drug Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年）

Global Anti–Oral Mucositis Drug Market Size, Status and Forecast 2021-2027
QYR2104Z0406 2021年4月 96Pages
QYResearch社発行の本調査資料では、抗口腔粘膜炎薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（うがい薬、鎮痛薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の口腔粘膜炎治療薬市場規模・現状・予測（2021年-2027年）

Global Oral Mucositis Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4305 2021年4月 95Pages
QYResearch社発行の本調査資料では、口腔粘膜炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法）、用途別市場規模（病院、歯科医院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓...

世界の口腔粘膜炎市場規模・現状・予測（2021年-2027年）

Global Oral Mucositis Market Size, Status and Forecast 2021-2027
QYR2104Z4304 2021年4月 134Pages
QYResearch社発行の本調査資料では、口腔粘膜炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（うがい薬、鎮痛薬、その他）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の口腔粘膜炎市場規模・現状・予測（2021年-2027年）

世界の抗ニキビ薬市場規模・現状・予測（2021年-2027年）

Global Anti Ance Drug Market Size, Status and Forecast 2021-2027
QYR2104Z0361 2021年4月 99Pages
QYResearch社発行の本調査資料では、抗ニキビ薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、処方薬）、用途別市場規模（局所、経口）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、...

世界の薬物検査用口腔液市場規模・現状・予測（2021年-2027年）

Global Drug Test Oral Fluid Market Size, Status and Forecast 2021-2027
QYR2104Z1994 2021年4月 97Pages
QYResearch社発行の本調査資料では、薬物検査用口腔液のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アンフェタミン（AMP）、バルビツール酸塩（BAR）、ベンゾジアゼピン（BZO）、ブプレノルフィン（BUP）、カンナビノイド（THC）、...

世界の抗緑内障薬市場規模・現状・予測（2021年-2027年）

Global Anti-glaucoma Drug Market Size, Status and Forecast 2021-2027
QYR2104Z0391 2021年4月 99Pages
QYResearch社発行の本調査資料では、抗緑内障薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（縮瞳薬、ベータ遮断薬、アドレナリン作動薬、炭酸脱水酵素阻害薬、プロスタグランジン誘導体剤、ペネトレート）、用途別市場規模（病院薬局、ドラッグス...

世界の抗緑内障薬市場規模・現状・予測（2021年-2027年）

世界の抗腫瘍薬市場規模・現状・予測（2021年-2027年）

Global Anti-tumor Drug Market Size, Status and Forecast 2021-2027
QYR2104Z0419 2021年4月 128Pages
QYResearch社発行の本調査資料では、抗腫瘍薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞毒性薬、非細胞毒性薬）、用途別市場規模（アルキル化剤、抗代謝薬、プラチナ抗腫瘍薬、アントラサイクリン抗腫瘍薬、微小管安定剤、内分泌療法薬、免...

世界のニキビ治療薬市場規模・現状・予測（2021年-2027年）

Global Acne Treatment Drug Market Size, Status and Forecast 2021-2027
QYR2104Z0020 2021年4月 98Pages
QYResearch社発行の本調査資料では、ニキビ治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、処方薬）、用途別市場規模（局所、経口）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア...

世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
世界の口腔粘膜炎市場規模・現状・予測（2021年-2027年） Mucositis occurs when cancer treatments break down the rapidly divided epithelial cells lining the gastro-intestinal tract (which goes from the mouth to the anus), leaving the mucosal tissue open to ulceration and infection. Mucosal tissue, also known as mucosa or the mucous membrane, lines all body…
世界の口腔粘膜炎市場規模・現状・予測（2021年-2027年） Mucositis occurs when cancer treatments break down the rapidly divided epithelial cells lining the gastro-intestinal tract (which goes from the mouth to the anus), leaving the mucosal tissue open to ulceration and infection. Mucosal tissue, also known as mucosa or the mucous membrane, lines all body…
世界の口腔粘膜炎治療薬市場規模・現状・予測（2021年-2027年） Oral mucositis (OM) is the inflammation of oral mucosa and is manifested by pain and erythema or ulcerations. This condition is generally seen as a complication due to side effects of chemotherapy and radiotherapy in cancer patients. The systemic effects of cytotoxic chemotherapy agents and radiatio…
世界の抗ニキビ薬市場規模・現状・予測（2021年-2027年） Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high…